Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 28, 2022
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
Thu, October 27, 2022
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
[ Thu, Oct 27th 2022
] - WOPRAI
John Ransom Downgraded (AMED) to Hold on, Oct 27th, 2022
John Ransom of Raymond James, Downgraded "Amedisys, Inc." (AMED) to Hold on, Oct 27th, 2022.
John has made no other calls on AMED in the last 4 months.
There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
These are the ratings of the 5 analyists that currently disagree with John
- Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $140 on, Wednesday, October 5th, 2022
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
- Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $154 on, Friday, July 29th, 2022
